Assignee
JUNO THERAPEUTICS INC
US62 patents
Top patents by PatentIndex Score
US11400115B2Aug 2, 2022
Methods for isolating, culturing, and genetically engineering immune cell populations for adoptive therapy
JUNO THERAPEUTICS INC18 citations91
US10889652B2Jan 12, 2021
Antibodies and chimeric antigen receptors specific for ROR1
JUNO THERAPEUTICS INC9 citations84
US10533055B2Jan 14, 2020
Antibodies and chimeric antigen receptors specific for CD19
JUNO THERAPEUTICS INC16 citations84
US10507219B2Dec 17, 2019
Methods and compositions for dosing in adoptive cell therapy
JUNO THERAPEUTICS INC10 citations83
US11944647B2Apr 2, 2024
Articles of manufacture and methods for treatment using adoptive cell therapy
JUNO THERAPEUTICS INC5 citations82
US11413310B2Aug 16, 2022
Articles of manufacture and methods for treatment using adoptive cell therapy
JUNO THERAPEUTICS INC12 citations82
US10738278B2Aug 11, 2020
Engineered cells for adoptive cell therapy
JUNO THERAPEUTICS INC8 citations82
US11066475B2Jul 20, 2021
Chimeric antigen receptors specific for B-cell maturation antigen and encoding polynucleotides
JUNO THERAPEUTICS INC10 citations80
US10363269B2Jul 30, 2019
Modified hepatitis post-transcriptional regulatory elements
JUNO THERAPEUTICS INC8 citations80
US11851678B2Dec 26, 2023
Methods for producing genetically engineered cell compositions and related compositions
JUNO THERAPEUTICS INC9 citations79
US10428351B2Oct 1, 2019
Methods for transduction and cell processing
JUNO THERAPEUTICS INC13 citations78
US11020429B2Jun 1, 2021
Vectors and genetically engineered immune cells expressing metabolic pathway modulators and uses in adoptive cell therapy
JUNO THERAPEUTICS INC9 citations74
US12296010B2May 13, 2025
Methods for isolating, culturing, and genetically engineering immune cell populations for adoptive therapy
JUNO THERAPEUTICS INC1 citations72
US12208137B2Jan 28, 2025
Methods for isolating, culturing, and genetically engineering immune cell populations for adoptive therapy
JUNO THERAPEUTICS INC4 citations72
US11266739B2Mar 8, 2022
Methods and compositions for adoptive cell therapy
JUNO THERAPEUTICS INC2 citations72
US11815514B2Nov 14, 2023
Methods and compositions related to toxicity associated with cell therapy
JUNO THERAPEUTICS INC2 citations71
US11623961B2Apr 11, 2023
Antibodies and chimeric antigen receptors specific for B-cell maturation antigen
JUNO THERAPEUTICS INC7 citations71
US11564946B2Jan 31, 2023
Methods associated with tumor burden for assessing response to a cell therapy
JUNO THERAPEUTICS INC2 citations71
US10786533B2Sep 29, 2020
Engineered cells for adoptive cell therapy
JUNO THERAPEUTICS INC4 citations69
US12193994B2Jan 14, 2025
Combination of a cell therapy and a gamma secretase inhibitor
JUNO THERAPEUTICS INC4 citations68
US12258580B2Mar 25, 2025
Process for generating therapeutic compositions of engineered cells
JUNO THERAPEUTICS INC2 citations67
US11561219B2Jan 24, 2023
Methods of enumerating particles present in a cell composition
JUNO THERAPEUTICS INC3 citations66
US11535903B2Dec 27, 2022
Methods and reagents for assessing the presence or absence of replication competent virus
JUNO THERAPEUTICS INC2 citations65
US11072660B2Jul 27, 2021
HPV-specific binding molecules
JUNO THERAPEUTICS INC4 citations64
US11793833B2Oct 24, 2023
Engineered B cells and related compositions and methods
JUNO THERAPEUTICS INC0 citations62
US11633426B2Apr 25, 2023
Methods and compositions for dosing in adoptive cell therapy
JUNO THERAPEUTICS INC1 citations62
US11919970B2Mar 5, 2024
Antibodies and chimeric antigen receptors specific for ROR1
JUNO THERAPEUTICS INC1 citations61
US11827714B2Nov 28, 2023
Antibodies and chimeric antigen receptors specific for CD19
JUNO THERAPEUTICS INC0 citations61
US12168027B2Dec 17, 2024
Methods associated with tumor burden for assessing response to a cell therapy
JUNO THERAPEUTICS INC0 citations60
US11740231B2Aug 29, 2023
Articles of manufacture and methods related to toxicity associated with cell therapy
JUNO THERAPEUTICS INC0 citations60
US12583904B2Mar 24, 2026
Articles of manufacture and methods for treatment using adoptive cell therapy
JUNO THERAPEUTICS INC0 citations59
US12304935B2May 20, 2025
Immunomodulatory polypeptides and related compositions and methods
JUNO THERAPEUTICS INC0 citations59
US11590167B2Feb 28, 2023
Methods and compositions for use of therapeutic T cells in combination with kinase inhibitors
JUNO THERAPEUTICS INC2 citations59
US12570749B2Mar 10, 2026
Anti-idiotypic antibodies to GPRC5D-targeted binding domains and related compositions and methods
JUNO THERAPEUTICS INC0 citations57
US12428486B2Sep 30, 2025
Chimeric antigen receptors specific for B-cell maturation antigen and encoding polynucleotides
JUNO THERAPEUTICS INC0 citations57
US12215348B2Feb 4, 2025
Methods for producing genetically engineered cell compositions and related compositions
JUNO THERAPEUTICS INC1 citations57
US12006356B2Jun 11, 2024
Anti-CCT5 binding molecules and chimeric antigen receptors comprising the same
JUNO THERAPEUTICS INC0 citations57
US12553024B2Feb 17, 2026
Serum-free media formulation for culturing cells and methods of use thereof
JUNO THERAPEUTICS INC0 citations56
US11851679B2Dec 26, 2023
Method of assessing activity of recombinant antigen receptors
JUNO THERAPEUTICS INC0 citations56
US11802295B2Oct 31, 2023
Methods for transduction and cell processing
JUNO THERAPEUTICS INC0 citations56
US12264371B2Apr 1, 2025
Methods and reagents for assessing the presence or absence of replication competent virus
JUNO THERAPEUTICS INC0 citations54
US11471489B2Oct 18, 2022
T cell receptors and engineered cells expressing same
JUNO THERAPEUTICS INC1 citations54
US12379375B2Aug 5, 2025
Methods for assessing cell surface glycosylation
JUNO THERAPEUTICS INC0 citations53
US12161670B2Dec 10, 2024
Phenotypic markers for cell therapy and related methods
JUNO THERAPEUTICS INC1 citations53
US12366580B2Jul 22, 2025
Methods for mass spectrometry analysis of engineered cell compositions
JUNO THERAPEUTICS INC0 citations52
US11952408B2Apr 9, 2024
HPV-specific binding molecules
JUNO THERAPEUTICS INC1 citations52
US12263190B2Apr 1, 2025
Methods and combinations for treatment and T cell modulation
JUNO THERAPEUTICS INC0 citations51
US12139526B2Nov 12, 2024
Modified chimeric receptors and related compositions and methods
JUNO THERAPEUTICS INC0 citations51
US11421287B2Aug 23, 2022
Methods for assessing the presence or absence of replication competent virus
JUNO THERAPEUTICS INC1 citations51
US11796534B2Oct 24, 2023
Methods for assessing cell surface glycosylation
JUNO THERAPEUTICS INC1 citations50
Showing the top 50 of 62 patents by PatentIndex Score.